FK506 ameliorates cell death features in Huntington's disease striatal cell models

Neurochemistry International

Volumn 59, Issue 5, 2011, Pages 600-609

  Rosenstock, Tatiana R ^a   De Brito, Olga Martins ^a   Lombardi, Vitoria ^a   Louros, Susana ^a   Ribeiro, Marcio ^a   Almeida, Sandra ^a   Ferreira, Ildete Luisa ^a   Oliveira, Catarina R ^a,b   Rego, A Cristina ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

3 Nitropropionic acid; Cell death; FK506; Mitochondrial dysfunction; Mutant huntingtin; Striatal neurons

Indexed keywords

3 NITROPROPIONIC ACID; APOPTOSIS INDUCING FACTOR; CASPASE 3; CYTOCHROME C; STAUROSPORINE; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CELL DEATH; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EXPOSURE; ENZYME ACTIVATION; HUNTINGTON CHOREA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL DEATH; CELL LINE; CORPUS STRIATUM; CYTOSOL; DNA FRAGMENTATION; HUMANS; HUNTINGTON DISEASE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NECROSIS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; NUCLEAR PROTEINS; PROPIONIC ACIDS; STAUROSPORINE; SUBCELLULAR FRACTIONS; TACROLIMUS;

ANIMALIA; MUS; RATTUS;

EID: 80052936684     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.04.009     Document Type: Article

References (45)

1. S. Almeida, A. Domingues, L. Rodrigues, C.R. Oliveira, and A.C. Rego FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures Neurobiol. Dis. 17 2004 435 444 (Pubitemid 39574877)
2. S. Almeida, A.C. Brett, I.N. Gois, C.R. Oliveira, and A.C. Rego Caspase-dependent and -independent cell death induced by 3-nitropropionic acid in rat cortical neurons J. Cell Biochem. 98 2006 93 101
3. A.B. Brillantes, K. Ondrias, A. Scott, E. Kobrinsky, E. Ondriasová, M.C. Moschella, T. Jayaraman, M. Landers, B.E. Ehrlich, and A.R. Marks Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein Cell 77 4 1994 513 523 (Pubitemid 24153992)
4. E. Brouillet, M.C. Guyot, V. Mittoux, S. Altairac, F. Conde, S. Palfi, and P. Hantraye Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat J. Neurochem. 70 1998 794 804
5. R.F. Castilho, O. Hansson, and P. Brundin FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons Exp. Neurol. 164 2000 94 101 (Pubitemid 30490726)
6. Y.S. Choo, G.V. Johnson, M. MacDonald, P.J. Detloff, and M. Lesort Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release Hum. Mol. Genet. 13 2004 1407 1420 (Pubitemid 39023049)
7. C.J. Coles, D.E. Edmondson, and T.P. Singer Inactivation of succinate dehydrogenase by 3-nitropropionate J. Biol. Chem. 254 1979 5161 5167
8. R.L. Cornea, F.R. Nitu, M. Samsó, D.D. Thomas, and B.R. Fruen Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer J. Biol. Chem. 285 25 2010 19219 19226
9. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat. Rev. Cancer 2 9 2002 647 656 (Pubitemid 37328916)
10. T.M. Dawson, J.P. Steiner, V.L. Dawson, J.L. Dinerman, G.R. Uhl, and S.H. Snyder Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity Proc. Natl. Acad. Sci. USA 90 1993 9808 9812 (Pubitemid 23328199)
11. S. Desagher, and J.C. Martinou Mitochondria as the central control point of apoptosis Trends Cell Biol. 10 9 2000 369 377 (Pubitemid 30612469)
12. K.T. Dineley, R. Kayed, V. Neugebauer, Y. Fu, W. Zhang, L.C. Reese, and G. Taglialatela Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice J. Neurosci. Res. 88 13 2010 2923 2932
13. J.M. Dubinsky, and Y. Levi Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons J. Neurosci. Res. 53 1998 728 741 (Pubitemid 28423880)
14. I.L. Ferreira, M.V. Nascimento, M. Ribeiro, S. Almeida, S.M. Cardoso, M. Grazina, J. Pratas, M.J. Santos, C. Januário, C.R. Oliveira, and A.C. Rego Mitochondrial-dependent apoptosis in Huntington's disease human hybrids Exp. Neurol. 222 2 2010 243 255
15. J.P. Griffith, J.L. Kim, E.E. Kim, M.D. Sintchak, J.A. Thomson, M.J. Fitzgibbon, M.A. Fleming, P.R. Caron, K. Hsiao, and M.A. Navia X-ray structure of calcineurin inhibited by the immunophilinimmunosuppressant FKBP12-FK506 complex Cell 82 1995 507 522
16. O. Hansson, A. Petersén, M. Leist, P. Nicotera, R.F. Castilho, and P. Brundin Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity Proc. Natl. Acad. Sci. USA 96 15 1999 8727 8732 (Pubitemid 29354859)
17. E. Hermel, J. Gafni, S.S. Propp, B.R. Leavitt, C.L. Wellington, J.E. Young, A.S. Hackam, A.V. Logvinova, A.L. Peel, S.F. Chen, V. Hook, R. Singaraja, S. Krajewsk, P.C. Goldsmith, H.M. Ellerby, M.R. Hayden, D.E. Bredesen, and L.M. Ellerby Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease Cell Death Differ. 11 2004 424 438 (Pubitemid 38489420)
18. D. Hernandez-Espinosa, and A.J. Morton Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation Brain Res. Bull. 69 2006 669 679 (Pubitemid 43728746)
19. L.S. Huang, G. Sun, D. Cobessi, A.C. Wang, J.T. Shen, E.Y. Tung, V.E. Anderson, and E.A. Berry 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme J. Biol. Chem. 281 2006 5965 5972 (Pubitemid 43847697)
20. S. Humbert, E.A. Bryson, F.P. Cordelieres, N.C. Connors, S.R. Datta, S. Finkbeiner, M.E. Greenberg, and F. Saudou The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt Dev. Cell 2 2002 831 837 (Pubitemid 34650078)
21. Y. Kitamura, Y. Itano, T. Kubo, and Y. Nomura Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice J. Neuroimmunol. 50 1994 221 224 (Pubitemid 24071788)
22. P. Kumar, and A. Kumar Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide Neurosci. Res. 63 4 2009 302 314
23. K.H. Lee, R. Won, U.J. Kim, G.M. Kim, M.-A. Chung, J.-H. Sohn, and B.H. Lee Neuroprotective effects of FK506 against excitotoxicity in organotypic hippocampal slice culture Neurosci. Lett. 474 2010 126 130
24. W.T. Lee, T. Itoh, and D. Pleasure Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons Neuroscience 113 2002 699 708 (Pubitemid 34874694)
25. H. Li, S.H. Li, H. Johnston, P. Shelbourne, and X.J. Li Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity Nat. Genet. 25 2000 385 389 (Pubitemid 32983427)
26. 2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease Arch. Biochem. Biophys. 410 2003 1 6 (Pubitemid 36268790)
27. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736 (Pubitemid 34827590)
28. R. Pardo, E. Colin, E. Régulier, P. Aebischer, N. Déglon, S. Humbert, and F. Saudou Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421 J. Neurosci. 26 5 2006 1635 1645 (Pubitemid 43237034)
29. Petrilli Guinart, A., Song, W., Bossy, B., Liot, G., Lubitz, S., Deassis, V., Johnson, J., Poquiz, P., TJong, J., Pouladi, M., Ghassemzadeh, S., Hayden, M., Masliah, E., Ellisman, M., Rouiller, I., Perkins, G., Bossy-Wetzel, E., 2009. Mutant huntingtin mediates neuronal injury by impairing mitochondrial fission and fusion balance. Program No. 303.8. Neuroscience Meeting Planner, Society for Neuroscience, Chicago, IL.
30. J.R. Pineda, R. Pardo, D. Zala, H. Yu, S. Humbert, and F. Saudou Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease Mol. Brain 2 2009 33
31. A.C. Rego, N.M. Monteiro, A.P. Silva, J. Gil, J.O. Malva, and C.R. Oliveira Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures J. Neurochem. 86 4 2003 792 804 (Pubitemid 36992216)
32. T.R. Rosenstock, V.C. Abílio, R. Frussa-Filho, B.H. Kiyomoto, and S.S. Smaili Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid Pharmacol. Biochem. Behav. 91 2009 327 332
33. T.R. Rosenstock, A.C.P. Carvalho, A. Jurkiewicz, R. Frussa-Filho, and S.S. Smaili Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid J. Neurochem. 88 2004 1220 1228 (Pubitemid 38280690)
34. T.R. Rosenstock, A.I. Duarte, and A.C. Rego Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench Curr. Drug Targets 2010 1218 1236
35. S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D.R. Goodlett, R. Aebersold, D.P. Siderovski, J.M. Penninger, and G. Kroemer Molecular characterization of mitochondrial apoptosis-inducing factor Nature 397 1999 441 446
36. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
37. F. Trettel, D. Rigamonti, P. Hilditch-Maguire, V.C. Wheeler, A.H. Sharp, F. Persichetti, E. Cattaneo, and M.E. MacDonald Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells Hum. Mol. Genet. 9 2000 2799 2809
38. J.C. Vis, M.M. Verbeek, R.M. de Waal, H.J. ten Donkelaar, and B. Kremer The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum Neuropathol. Appl. Neurobiol. 27 1 2001 68 76 (Pubitemid 32291189)
39. J.C. Vis, R.T. de Boer-van Huizen, M.M. Verbeek, R.M. de Waal, H.J. ten Donkelaar, and B. Kremer 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures Neurosci. Lett. 329 2002 86 90
40. J.P. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384 (Pubitemid 28237321)
41. 2+- induced apoptosis through calcineurin dephosphorylation of BAD Science 284 1999 339 343
42. S.C. Warby, E.Y. Chan, M. Metzler, L. Gan, R.R. Singaraja, S.F. Crocker, H.A. Robertson, and M.R. Hayden Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo Hum. Mol. Genet. 14 2005 1569 1577 (Pubitemid 40823464)
43. C. Yardin, F. Terro, M. Lesort, F. Esclaire, and J. Hugon FK506 antagonizes apoptosis and c-jun protein expression in neuronal cultures NeuroReport 9 1998 2077 2080 (Pubitemid 28300569)
44. X. Xifró, A. Giralt, A. Saavedra, J.M. García- Martínez, M. Díaz-Hernández, J.J. Lucas, J. Alberch, and E. Pérez-Navarro Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity Neurobiol. Dis. 36 3 2009 461 469
45. X. Xifró, J.M. García-Martínez, D. Del Toro, J. Alberch, and E. Pérez-Navarro Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells J. Neurochem. 105 5 2008 1596 1612 (Pubitemid 351678484)